| scholarly article | Q13442814 |
| P2093 | author name string | Q Tang | |
| K Lee | |||
| K-M Lee | |||
| V Nguyen | |||
| S-M Kang | |||
| P2860 | cites work | Requirement of the chemokine receptor CXCR3 for acute allograft rejection | Q24676298 |
| Ex vivo generation of human alloantigen-specific regulatory T cells from CD4(pos)CD25(high) T cells for immunotherapy | Q33336577 | ||
| Antigen-specific dependence of Tr1-cell therapy in preclinical models of islet transplant | Q33604471 | ||
| Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia | Q33629928 | ||
| Homeostatic proliferation is a barrier to transplantation tolerance | Q33731951 | ||
| Specificity of CD4+CD25+ regulatory T cell function in alloimmunity | Q33736744 | ||
| In vivo tracking of 'color-coded' effector, natural and induced regulatory T cells in the allograft response | Q33950788 | ||
| Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation | Q73679954 | ||
| IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells | Q75303125 | ||
| Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis | Q78404404 | ||
| In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance | Q79143624 | ||
| CD25+CD4+ regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: antigen-specific reactivation in vivo is critical for bystander regulation | Q81406391 | ||
| Immunology. Regulatory T cells get their chance to shine | Q84204868 | ||
| Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes | Q34585878 | ||
| "Infectious" transplantation tolerance. | Q34726892 | ||
| CD4+CD25+ regulatory T cells control CD8+ T-cell effector differentiation by modulating IL-2 homeostasis | Q34937677 | ||
| Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. | Q34966662 | ||
| Requirements for prolongation of allograft survival with regulatory T cell infusion in lymphosufficient hosts | Q35044185 | ||
| Regulatory T cells selectively control CD8+ T cell effector pool size via IL-2 restriction | Q35204547 | ||
| Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly | Q35553381 | ||
| Tregs and transplantation tolerance | Q35951541 | ||
| Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide | Q36355820 | ||
| In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes | Q36399048 | ||
| CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. | Q36399104 | ||
| Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity | Q36551599 | ||
| Immune privilege induced by regulatory T cells in transplantation tolerance | Q36593774 | ||
| CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects | Q36826059 | ||
| ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms | Q36936238 | ||
| Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells | Q37180691 | ||
| Regulatory T cells as therapeutic cells. | Q37342595 | ||
| Regulatory T cells in transplantation: transferring mouse studies to the clinic | Q37629519 | ||
| CD4(+)Foxp3(+) regulatory T cell therapy in transplantation | Q37968576 | ||
| Regulatory T-cell therapy for transplantation: how many cells do we need? | Q38025843 | ||
| Regulatory T cells in transplantation: what we know and what we do not know | Q39957163 | ||
| CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism | Q40416864 | ||
| The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade | Q40624980 | ||
| Transplantation of pancreatic islets into the kidney capsule of diabetic mice | Q41902679 | ||
| A novel clinically relevant approach to tip the balance toward regulation in stringent transplant model. | Q42827367 | ||
| Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice. | Q42915120 | ||
| Murine pancreatic islet isolation | Q43189242 | ||
| Murine skin transplantation | Q43243261 | ||
| A new T-cell receptor transgenic model of the CD4+ direct pathway: level of priming determines acute versus chronic rejection. | Q46032301 | ||
| Preferential priming of alloreactive T cells with indirect reactivity | Q46670813 | ||
| Molecular signature of CD8+ T cell exhaustion during chronic viral infection. | Q51970485 | ||
| Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it. | Q51983574 | ||
| High-resolution characterization of cytokine-producing alloreactivity in naive and allograft-primed mice. | Q52039522 | ||
| Regulation and privilege in transplantation tolerance. | Q53530470 | ||
| Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. | Q54073234 | ||
| NOD mice have a generalized defect in their response to transplantation tolerance induction. | Q54095945 | ||
| The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells | Q56902123 | ||
| Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements | Q57228054 | ||
| Deficient Positive Selection of CD4 T Cells in Mice Displaying Altered Repertoires of MHC Class II–Bound Self-Peptides | Q60641123 | ||
| Following a diabetogenic T cell from genesis through pathogenesis | Q70488192 | ||
| Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question | Q73365765 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 27-38 | |
| P577 | publication date | 2013-11-13 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | Attenuation of donor-reactive T cells allows effective control of allograft rejection using regulatory T cell therapy | |
| P478 | volume | 14 |
| Q34601943 | Adipose-derived stromal cells promote allograft tolerance induction |
| Q39279238 | Cell Therapy in Kidney Transplantation: Focus on Regulatory T Cells |
| Q94429573 | Clinical intraocular islet transplantation is not a number issue |
| Q26745435 | Combined Bone Marrow and Kidney Transplantation for the Induction of Specific Tolerance |
| Q88663316 | Contemporary Strategies and Barriers to Transplantation Tolerance |
| Q58792298 | Direct recognition of hepatocyte-expressed MHC class I alloantigens is required for tolerance induction |
| Q41658209 | Donor-Reactive Regulatory T Cell Frequency Increases During Acute Cellular Rejection of Lung Allografts |
| Q49789996 | Dysfunctional immunoregulation in human liver allograft rejection associated with compromised galectin-1/CD7 pathway function |
| Q39062014 | Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection. |
| Q64075115 | Foxp3 Regulatory and Conventional CD4 T Cells Display Similarly High Frequencies of Alloantigen-Reactive Cells |
| Q92593515 | Gal-1 regulates dendritic cells-induced Treg/Th17 balance though NF-κB/RelB-IL-27 pathway |
| Q36786632 | Induced Foxp3(+) T Cells Colonizing Tolerated Allografts Exhibit the Hypomethylation Pattern Typical of Mature Regulatory T Cells |
| Q38260080 | Interpretation of transplant biopsies and immune responses following Treg cell therapy |
| Q34729072 | Islet cell transplant and the incorporation of Tregs. |
| Q91681739 | Local Delivery of Regulatory T Cells Promotes Corneal Allograft Survival |
| Q50069723 | Lung Injury and Loss of Regulatory T Cells Primes for Lung-Restricted Autoimmunity |
| Q38224758 | Lung transplantation: chronic allograft dysfunction and establishing immune tolerance |
| Q91707988 | Mechanisms of Immune Tolerance in Liver Transplantation-Crosstalk Between Alloreactive T Cells and Liver Cells With Therapeutic Prospects |
| Q100694573 | Multiscale fluorescent tracking of immune cells in the liver with a highly biocompatible far-red emitting polymer probe |
| Q26823540 | New insights into the mechanisms of Treg function |
| Q90197782 | Next-generation regulatory T cell therapy |
| Q40402774 | Prevention of Allograft Rejection by Use of Regulatory T Cells With an MHC-Specific Chimeric Antigen Receptor. |
| Q48668293 | Regulatory T Cells: Molecular and Cellular Basis for Immunoregulation |
| Q34454926 | Regulatory T cell-derived exosomes: possible therapeutic and diagnostic tools in transplantation |
| Q38191610 | Regulatory T cells as immunotherapy |
| Q89910768 | Regulatory T cells in solid organ transplantation |
| Q57471979 | Regulatory T cells in the treatment of disease |
| Q35995670 | Rejection triggers liver transplant tolerance: Involvement of mesenchyme-mediated immune control mechanisms in mice |
| Q38963375 | Restoring Regulatory T Cells in Type 1 Diabetes |
| Q53824120 | Stability of Chimerism in Non-Obese Diabetic Mice Achieved By Rapid T Cell Depletion Is Associated With High Levels of Donor Cells Very Early After Transplant. |
| Q88957417 | Stem Cell Therapies for Treating Diabetes: Progress and Remaining Challenges |
| Q59130097 | T cell Allorecognition Pathways in Solid Organ Transplantation |
| Q26827749 | THERAPY OF ENDOCRINE DISEASE: Islet transplantation for type 1 diabetes: so close and yet so far away |
| Q36372616 | Targeting Treg signaling for the treatment of autoimmune diseases |
| Q26851647 | Tempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cells |
| Q35205330 | Therapeutic regulatory T cells subvert effector T cell function in inflamed islets to halt autoimmune diabetes |
| Q38256369 | Tolerance in organ transplantation: from conventional immunosuppression to extracellular vesicles. |
| Q26778646 | Tolerogenic Dendritic Cells on Transplantation: Immunotherapy Based on Second Signal Blockage |
| Q61805676 | Transient increase of activated regulatory T cells early after kidney transplantation |
| Q54686684 | Transplant tolerance by Treg therapy. |
| Q39406891 | Transplant trials with Tregs: perils and promises |
| Q91768573 | Treg cell-based therapies: challenges and perspectives |
| Q37694801 | Utilization of leukapheresis and CD4 positive selection in Treg isolation and the ex-vivo expansion for a clinical application in transplantation and autoimmune disorders |
Search more.